Delivery Order SPE2DR25D1106-SPE2DR26FJF6V
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,517.26 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram unit on December 3, 2025, with completion scheduled for December 4, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,044.10 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in 10-gram units. Issued on December 8, 2025, with an ultimate completion date of December 9, 2025, this firm fixed-price delivery order represents a small-value transaction within the federal medical supply procurement process. The award was made without a set-aside designation, indicating competitive selection among qualified vendors. AmerisourceBergen...
- The Defense Logistics Agency awarded a $14,484.65 delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Proctofoam-HC 1%-1% foam in 10-gram units. This is a firm fixed-price, competitive award with no set-aside designation, with an ultimate completion date of November 7, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary operations. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,899.35 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram unit. This is a firm fixed price, non-set-aside contract with an ultimate completion date of November 25, 2025, one day after the award date. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs, particularly supporting military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for Proctofoam-HC 1%-1% foam in a 10-gram unit, with a ceiling value of $1,048.10. This competitively awarded contract uses firm fixed pricing and is classified as a non-set-aside procurement. The delivery order is expected to be completed by August 18, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% foam in a 10-gram quantity on December 3, 2025, with a ceiling value of $1,539.94. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 4, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is located. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram unit with a ceiling value of $1,711.00. This firm fixed price delivery order, effective November 24, 2025, with completion targeted for November 25, 2025, represents a child order under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The award carries no set-aside designation, indicating it was competitively awarded. The product will be performed...
- The Defense Logistics Agency awarded a $11,418.86 delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Proctofoam-HC 1%-1% Foam in 10-gram units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 16, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $9,099.35 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in 10-gram units. This is a firm fixed-price, non-competitive delivery order executed on November 17, 2025, with an ultimate completion date of November 18, 2025. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. As a delivery order, this contract represents a task issued under a larger indefinite delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Proctofoam-HC 1%-1% foam in 10-gram units, with a ceiling value of $1,048.10. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The order is set for ultimate completion on July 23, 2025, and will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order is issued...
- SPE2DR25D1106Indefinite Delivery Contract
- SPE2DR25D1106-SPE2DR26FJF6VDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram unit with a ceiling value of $2,185.04. This firm fixed-price delivery order was awarded on December 30, 2025, with an ultimate completion date of December 31, 2025, and represents a non-set-aside competitive award. The product will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to fulfill diverse medical supply requirements across multiple therapeutic domains through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 12/29/25 |